文献速递甲状腺疾病肥胖与代谢综合征

甲状腺与肝脏之间的代谢与功能交互作用

Metabolic and Functional Cross Talk Between the Thyroid and Liver.
PubMed 文献 · Thyroid · 2025-05-26

本文综述甲状腺疾病及其治疗对肝脏生理、代谢和病理的影响,以及肝病对甲状腺功能的反向调节;并总结甲状腺激素在代谢综合征、高脂血症和代谢功能障碍相关脂肪性肝病(MASLD)中的作用及甲状腺模拟剂治疗代谢病的证据。

要点

  • 甲状腺功能减退和「肝内」甲状腺功能减退可促进高胆固醇血症和MASLD的发生。
  • 肝功能障碍可通过降低甲状腺激素浓度及其对外周组织的作用来调节甲状腺功能。
  • 甲状腺模拟剂治疗MASLD的证据正在积累,重塑了对甲状腺-肝脏关系的理解。

核心结论

  • 认识甲状腺及甲状腺激素对肝脏代谢和燃料利用的影响,以及肝脏在调节全身甲状腺激素作用中的作用,对甲状腺和/或肝脏疾病患者的最佳临床管理很重要。

研究设计与样本

  • 本文为综述,检索范围未在摘要中报告。

主要发现

  • 甲状腺功能减退和甲状腺功能亢进均影响肝脏碳水化合物和脂肪代谢,调节循环葡萄糖、胆固醇和甘油三酯水平。
  • 甲状腺功能减退和「肝内」甲状腺功能减退促进高胆固醇血症和MASLD的发生。
  • 肝功能障碍可通过降低甲状腺激素浓度及其对外周组织的作用来调节甲状腺功能。
  • 综述描述了甲状腺激素在代谢综合征、高脂血症和MASLD等代谢状况中起重要作用的临床和实验证据。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: The liver and thyroid have complicated effects on each other's functions and metabolic homeostasis in the body. Both hypo- and hyperthyroidism influence hepatic carbohydrate and fat metabolism to regulate circulating glucose, cholesterol, and triglyceride levels. Hypothyroidism and "intrahepatic" hypothyroidism also contribute to the development of hypercholesterolemia and metabolic dysfunction-associated steatotic liver disease (MASLD). Likewise, hepatic dysfunction can modulate thyroid function by reducing thyroid hormone (TH) concentrations and their effects on peripheral tissues. Summary: In this review, we examine the impact of thyroid disorders and their treatment on hepatic physiology, metabolism, and pathology, as well as the influence of liver disease on thyroid function. We also describe the clinical and experimental evidence for THs playing significant roles in metabolic conditions such as metabolic syndrome, hyperlipidemia, and MASLD. Additionally, we summarize the current literature on the use of thyromimetics for the treatment of metabolic diseases. Conclusions: Recognizing the effects of the thyroid and THs on hepatic metabolism and fuel utilization, and the liver's role in modulating systemic TH action, is important for optimal clinical management of patients with thyroid and/or liver diseases. New emerging concepts on TH actions in the liver and the efficacy of thyromimetics for the treatment of MASLD have reshaped our understanding of the thyroid-liver relationship and the roles of THs in the pathogenesis and treatment of metabolic diseases.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Chng CL, Goh GBB, Yen PM, et al. Metabolic and Functional Cross Talk Between the Thyroid and Liver. Thyroid. 2025. PMID: 40420529. doi:10.1089/thy.2025.0178

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。